Cargando…

Effects of medical therapies on retinopathy progression in type 2 diabetes: Is blood pressure control the lower the better?

Detalles Bibliográficos
Autores principales:	Chang, Chia‐Hsiun, Chuang, Lee‐Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2011
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015542/ https://www.ncbi.nlm.nih.gov/pubmed/24843468 http://dx.doi.org/10.1111/j.2040-1124.2010.00085.x

Ejemplares similares

Glycated hemoglobin variability and retinopathy progression in type 1 diabetes: Is month‐to‐moth instability a better predictor?
por: Chang, Chia‐Hsuin, et al.
Publicado: (2013)

Microalbuminuria and diabetic retinopathy in type 2 diabetic patients: From risk association to risk prediction
por: Chang, Chia‐Hsuin, et al.
Publicado: (2013)

Cardiovascular safety of long‐acting insulin analogs in type 2 diabetes patients: Is there a better basal insulin?
por: Chang, Chia‐Hsuin, et al.
Publicado: (2017)

The Role of Dyslipidemia Control in the Progression of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus
por: Chatziralli, Irini P.
Publicado: (2017)

Fetal exposure to parental smoking and the risk of type 2 diabetes: Are lifestyle‐related factors more important?
por: Chang, Chia‐Hsuin, et al.
Publicado: (2015)

Commentary: Predictors of development and progression of diabetic retinopathy: A precis
por: Moharana, Bruttendu, et al.
Publicado: (2021)

Commentary on risk factors for first and subsequent cardiovascular disease events in type 1 diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study
por: Lin, Chun‐Hsien, et al.
Publicado: (2020)

Antihypertensive Treatment and Blood Pressure in Diabetic and Nondiabetic Patients: The lower, the better?
por: Mancia, Giuseppe, et al.
Publicado: (2011)

Blood Pressure: The Lower, the Better: The con side
por: Grossman, Ehud
Publicado: (2011)

Debate: does it matter how you lower blood pressure?
por: McInnes, Gordon T
Publicado: (2001)

Debate: Does it matter how you lower blood pressure?
por: Alderman, Michael H
Publicado: (2000)

BLOOD PRESSURE IS ASSOCIATED  WITH DIABETIC RETINOPATHY  IN TYPE 1 BUT NOT IN TYPE 2 DIABETES
por: Bulum, Tomislav, et al.
Publicado: (2022)

Predictors of Development and Progression of Retinopathy in Patients with Type 2 Diabetes: Importance of Blood Pressure Parameters
por: Cardoso, Claudia R. L., et al.
Publicado: (2017)

Commentary: Vitrectomy for proliferative diabetic retinopathy in patients with type 1 diabetes mellitus
por: Tekchandani, Uday, et al.
Publicado: (2021)

Clocking in on Diabetic Retinopathy
por: Kleinman, Mark E., et al.
Publicado: (2013)

HbA(1c): The lower the better?
por: Araki, Eiichi, et al.
Publicado: (2011)

Commentary: Burden of diabetic retinopathy
por: Bhattacharjee, Harsha, et al.
Publicado: (2021)

Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT?
por: Gavras, Irene, et al.
Publicado: (2001)

Antagonizing Wnt Pathway in Diabetic Retinopathy
por: Zhao, Ling, et al.
Publicado: (2013)

Novel strategy for screening of diabetic retinopathy
por: Takagi, Hitoshi
Publicado: (2017)

Commentary: Oral management of diabetic retinopathy
por: Delhiwala, Kushal, et al.
Publicado: (2021)

Advances in the Medical Treatment of Diabetic Retinopathy
por: Simó, Rafael, et al.
Publicado: (2009)

T helper 17 cells: A new actor on the stage of type 2 diabetes and aging?
por: Chang, Yi‐Cheng, et al.
Publicado: (2021)

Commentary: From diabetic retinopathy toward diabetic retinal disease
por: Saurabh, Kumar, et al.
Publicado: (2021)

Commentary: Diabetic retinopathy and its correlation with other diabetic complications
por: Delhiwala, Kushal, et al.
Publicado: (2021)

The Impact of Systolic Blood Pressure, Pulse Pressure, and Their Variability on Diabetes Retinopathy among Patients with Type 2 Diabetes
por: Lou, Qingqing, et al.
Publicado: (2022)

The Role of Glycemic Control and Variability in Diabetic Retinopathy
por: Chatziralli, Irini P.
Publicado: (2017)

Comment on: Serum cholesterol and LDL-C in association with level of diastolic blood pressure in type 2 diabetic patients
por: Nasri, Hamid
Publicado: (2012)

Commentary: Role of optical coherence tomography-angiography in diabetes mellitus: Utility in diabetic retinopathy and a comparison with fluorescein angiography in vision threatening diabetic retinopathy
por: Rana, Vipin, et al.
Publicado: (2021)

Direct Effects of PPARα Agonists on Retinal Inflammation and Angiogenesis May Explain How Fenofibrate Lowers Risk of Severe Proliferative Diabetic Retinopathy
por: Abcouwer, Steven F.
Publicado: (2013)

Association between interarm blood pressure differences and diabetic retinopathy in patients with type 2 diabetes
por: Lee, Ji Hyun, et al.
Publicado: (2020)

Lower is better in hypertension, but how low should blood pressure be targeted?
por: Touyz, Rhian M.
Publicado: (2016)

Curious relationship between cognitive impairment and diabetic retinopathy
por: Kawamura, Takahiko, et al.
Publicado: (2015)

Diabetic retinopathy classification for supervised machine learning algorithms
por: Nakayama, Luis Filipe, et al.
Publicado: (2022)

Pulmonary artery occlusion pressure estimation by transesophageal echocardiography: is simpler better?
por: Voga, Gorazd
Publicado: (2008)

Urinary adiponectin and progression of diabetic nephropathy in type 1 diabetes
por: Ha, Kyoung Hwa, et al.
Publicado: (2015)

A roadmap to medical nutrition therapy in type 2 diabetes
por: Shalit, Almog, et al.
Publicado: (2023)

Different retinopathy phenotypes in type 2 diabetes predict retinopathy progression
por: Marques, Inês P., et al.
Publicado: (2020)

(Pro)renin Receptor: A Treatment Target for Diabetic Retinopathy?
por: Wilkinson-Berka, Jennifer L., et al.
Publicado: (2009)

Retinopathy: A sign of cerebral small vessel disease in diabetes?
por: Umemura, Toshitaka, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tm4uohabs28mgt6lg1elavpao6